Neurology:人工智能,辅助诊断颞叶癫痫

2021-09-06 Freeman MedSci原创

这个预测TLE侧向的模型是以现成的常规MRI对比度为基础的,并提供了比视觉放射学评估更多的准确性

许多药物难治性颞叶癫痫(TLE)患者出现海马体硬化(hippocampal sclerosis ,HS)。MRI有助于识别这种可能形成致痫灶基质的病变,从而简化手术前的评估。

海马硬化的主要影像学特征是海马体积的损失,通常与低密度T1和高密度T2加权信号有关。这些特征的生物学有效性已经通过MRI和组织病理学的联合分析得到证实,表明细胞密度降低和胶质增生分别与萎缩和T2高强化正相关。

然而,在临床实践中,在30-50%有明确的TLE临床电学证据的手术人选中,MRI仍不能显示海马的病变。这一广泛的范围可能部分归因于不理想的成像方案和有限的专业经验。

此外,虽然定量分析,包括海马体积测量、基于体素的形态测量、T2松弛测量( T2 relaxometry)和FLAIR信号强度的测量已被证明比视觉评估更敏感,但它们仍未得到充分利用。值得注意的是,HS的体内特征受神经元缺失和胶质增生的严重程度的影响,以孤立的胶质增生为典型的微妙形式往往能逃避检测。

因此,许多MRI未显示的患者可能要接受颅内脑电图检查,这种检查的风险与切除性手术相似,而且费用很高。


尽管有大量的神经影像学文献评估TLE的海马结构完整性,但绝大多数的研究都是针对群体层面的变化。另一方面,个别分析通常利用单一的对比,将其归一化为健康受试者的分布,很少解决MRI阴性患者的侧重点问题。

藉此,加拿大麦吉尔大学的Benoit Caldairou等人实施一个机器学习框架,依靠现成的常规T1和T2加权对比,对个体患者的HS进行侧向分析。

由于HS的典型特征是T1加权的低密度和T2加权的高密度,他们还通过将FLAIR强度除以T1加权的强度来生成一个合成对比,从而最大限度地提高它们的综合贡献,以检测完整的HS光谱。万博manbetx登录 将该分类器应用于TLE中HS的MRI特征,并在两个独立的队列中评估其普遍性。

他们训练了一个基于表面的线性判别分类器(surface-based linear discriminant classifier ),使用T1加权(形态)和T2加权以及FLAIR/T1(强度)特征。

该分类器在60名TLE患者(平均年龄:35.6岁;58%为女性)身上进行了训练,这些患者有组织学证实的海马硬化症(HS)。根据神经放射学读数,42%的病例被认为是MRI阴性的(40%是根据海马体积测定)。

预测模型自动将患者标记为左侧或右侧TLE。侧向的准确性(Lateralization accuracy )与脑电-临床数据进行了比较,包括手术的一侧。在两个独立的TLE队列中进一步评估了分类器的准确性,这些队列具有相似的人口统计学和电临床特征(n=57;58%MRI阴性)。

他们发现:无论HS的在MRI上的可视性如何,总体侧化准确率为93%(95%;CI 92% - 94%)。在MRI阴性的TLE中,T2和FLAIR/T1强度的组合在训练(84%,曲线下面积(AUC):0.95±0.02)和验证队列(队列1:90%,AUC:0.99;队列2:76%,AUC:0.94)中都提供了最高的准确性。

这个预测TLE侧向的模型是以现成的常规MRI对比度为基础的,并提供了比视觉放射学评估更多的准确性。T1加权强度降低和T2加权强度增加的综合贡献使得合成FLAIR/T1对比度对MRI阴性的HS特别有效,为广泛的临床转化奠定了基础。


原文出处:
Caldairou B, Foit NA, Mutti C, et al. An MRI-Based Machine Learning Prediction Framework to Lateralize Hippocampal Sclerosis in Patients With Temporal Lobe Epilepsy. Neurology. Published online September 2, 2021:10.1212/WNL.0000000000012699. doi:10.1212/WNL.0000000000012699

版权声明:
本网站所有内容来源注明为“万博manbetx登录 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于万博manbetx登录 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“万博manbetx登录 医学”。其它来源的文章系转载文章,或“万博manbetx登录 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与万博manbetx登录 联系,万博manbetx登录 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-11-02 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-09 刘明国

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-07 121f8b51m59(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-07 ms9000001304183114

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2001459, encodeId=8d7f20014596a, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 02 07:26:38 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016173, encodeId=e19310161e39d, content=学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee662910810, createdName=刘明国, createdTime=Thu Sep 09 22:32:37 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512250, encodeId=855c1512250f2, content=<a href='/topic/show?id=488f100e806b' target=_blank style='color:#2F92EE;'>#颞叶癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100780, encryptionId=488f100e806b, topicName=颞叶癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f010449023, createdName=ms3994565386320060, createdTime=Wed Sep 08 20:26:38 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015300, encodeId=becc101530039, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6052296331, createdName=121f8b51m59(暂无昵称), createdTime=Tue Sep 07 10:00:29 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015257, encodeId=0234101525efc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Tue Sep 07 08:23:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015252, encodeId=d997101525219, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3af81637571, createdName=songlijun11, createdTime=Tue Sep 07 08:02:36 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-07 songlijun11

    学习了

    0

相关manbetx手机版登录

Annals of Neurology: 癫痫发作后精神病由癫痫和精神病遗传易感性共同作用造成

在一种常见疾病中,疾病生物学(癫痫发作)和特质易感性(精神分裂症)相互作用产生了特定结果(发作后精神病)。

Neurology-万人随访10年:晚发性癫痫,死亡率比无癫痫者死亡率更高

Neurology-万人随访10年:晚发性癫痫,死亡率比无癫痫者死亡率更高

JAMA Neurology: 脑出血后,哪种癫痫预防方式更好?

短期(7天)的预防措施在sICH后的长期治疗中占优势

京新药业与韩国B-PS公司达成合作,引进癫痫First in Class创新药

8月26日,浙江京新药业股份有限公司(以下简称“京新药业”)与韩国Bio-Pharm Solutions Co. Ltd.(以下简称“B-PS公司”)签

JAMA Neurology : 新型抗癫痫药物,是否增加患者自杀风险?

目前没有证据表明本研究中评估的5种ASMs会增加癫痫病人的自杀性并值得发出自杀性等级警告。

梳理那些可以治疗癫痫的中药

中草药治疗癫痫的历史悠久。由于西方抗癫痫治疗的副作用以及对更容易获得的治疗的追求,补充和替代药物变得流行。一些中草药已被证明具有抗癫痫作用,不同草药的联合使用通过各种机制发挥抗惊厥作用。

拓展阅读

年纪轻轻左手突然不听使唤,是癫痫还是中风?一场罕见病的破解之路

29 岁的小张突发怪病,有癫痫发作、肢体无力症状。经检查,最终通过血清细胞基因分析确诊为 MOG 抗体相关疾病,介绍了疾病特点、常见症状、治疗方法。

“氯巴占”进医保了,临床如何正确使用?

癫痫影响众多人口,药物难治性癫痫约占 1/3,氯巴占是其 “救命药”,2024 年入医保,介绍其作用机制、代谢、用法用量、监测及注意事项等。

郭珍立教授:关注癫痫的中西医结合治疗,探索预防新前沿

本文围绕癫痫的中西医结合治疗与预防,郭珍立教授阐述抗癫痫药物分类及机制、中药作用,分析影响患者依从性因素及措施,介绍高危人群预防办法,还谈及医院特色优势及癫痫治疗趋势、中西医结合角色。

Neurology:阿尔茨海默病和癫痫发作患者癫痫病灶与 Tau 蛋白和Aβ沉积位置以及脑萎缩的关联

本研究结果揭示了 AD 早期临床阶段致癫痫病灶与 tau 沉积、淀粉样蛋白沉积和神经变性之间的空间关联。

217项美国在研的癫痫基金简述,这两项课题的设计值得你借鉴(2024)

万博manbetx登录 仅对美国国立卫生研究院(NIH)资助的在研癫痫相关项目进行梳理,希望给同仁们的选题思路提供一点启发。

吡仑帕奈治疗癫痫,您用对了吗?

介绍吡仑帕奈作为新型抗癫痫药物,通过抑制谷氨酸活动发挥作用,阐述其在癫痫治疗中的应用、适用症、专家共识及不良反应等。

2023 日本manbetx手机版 :儿童癫痫持续状态的治疗

日本儿童神经病学学会(JSCN,Japanese Society of Child Neurology) · 2024-12-02

2024 ILAE共识建议:儿童和青少年癫痫患者焦虑和抑郁的诊断和治疗

国际抗癫痫联盟(ILAE,International League Against Epilepsy) · 2024-09-25